China NMPA Product Recall - Polylactic acid hydroxyapatite screws

Smith & Nephew, Inc., the manufacturer, has announced a voluntary Class II recall of specific batches of its polylactic acid hydroxyapatite screws. This action was officially reported by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. The primary reason for this recall stems from identified labeling errors on certain products. Operating under the regulatory framework of the National Medical Products Administration (NMPA), as evidenced by the National Medical Device Registration Certificate No. 20153133943, this recall highlights the company's commitment to product integrity. It is crucial to note that, despite being processed through the NMPA's reporting channels, the recall explicitly states that it does not impact products distributed within the Chinese market. This is a proactive, voluntary measure undertaken by Smith & Nephew, rather than being a result of an NMPA inspection. The required action involves the comprehensive identification, containment, and retrieval of all potentially affected product batches from the market to mitigate any risks associated with the labeling discrepancies. This ensures adherence to established quality control protocols and maintains patient safety standards. Detailed information regarding the specific models, specifications, and affected batch numbers is documented in the attached "Medical Device Recall Event Report Form," providing transparency on the scope of the recall.